Effect and Safety of Menatetrenone on Treatment of Postmenopausal Osteoporosis.
Phase of Trial: Phase III
Latest Information Update: 23 Apr 2013
At a glance
- Drugs Menatetrenone (Primary) ; Alfacalcidol
- Indications Postmenopausal osteoporosis
- Focus Therapeutic Use
- Sponsors Eisai Co Ltd
- 10 Jun 2017 Biomarkers information updated
- 22 Dec 2009 Actual number of patients (240) added as reported by ClinicalTrials.gov.
- 22 Dec 2009 Actual end date (Jan 2007) added as reported by ClinicalTrials.gov.